CRISPR/Cas9 technology generated a CA to G change resulting in a stop codon and termination at methionine 533 (p.M533*). This corresponds to human 4:49034669 CA/C;Leu533Ter. Immunohistochemistry shows loss of expression in the ventricular epithelia of homozygous mice. (J:310176)